Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients.

Takeo NakajimaTatsuya NaganoYoshiharu MiyataShoko MurakamiSatoshi MitsuyukiYohei FunakoshiKimikazu YakushijinHitoshi HorimotoYoshihiro NishimuraKazuyuki Kobayashi

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2022)

The use of inhaled corticosteroids did not reduce the antibody titer against SARS-CoV-2 spike protein. Clinicians should continue treatment with inhaled corticosteroids if indicated.

Keyphrases

amino acid
sars cov
cystic fibrosis
end stage renal disease
respiratory syndrome coronavirus
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
palliative care
patient reported
protein protein